Page last updated: 2024-09-03

1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride and Anochlesia

1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride has been researched along with Anochlesia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbaoui, J; Chagraoui, A; Mocaƫr, E; Protais, P1

Other Studies

1 other study(ies) available for 1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride and Anochlesia

ArticleYear
Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    European journal of pharmacology, 1994, Dec-12, Volume: 271, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Benzamides; Benzazepines; Catalepsy; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Grooming; Male; Mice; Piperazines; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior

1994